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Abstract
Background: H-NS is a DNA-binding protein with central roles in gene regulation and nucleoid
structuring in Escherichia coli. There are over 60 genes that are influenced by H-NS many of which
are involved in metabolism. To determine the significance of H-NS-regulated genes in metabolism
and stress tolerance, an hns mutant of E. coli O157:H7 was generated (hns::nptI, FRIK47001P) and
its growth, metabolism, and gastrointestinal passage compared to the parent strain (43895) and
strain FRIK47001P harboring pSC0061 which contains a functional hns and 90-bp upstream of the
open-reading frame.
Results: The hns mutant grew slower and was non-motile in comparison to the parent strain.
Carbon and nitrogen metabolism was significantly altered in the hns mutant, which was incapable
of utilizing 42 carbon, and 19 nitrogen sources that the parent strain metabolized. Among the non-
metabolized substrates were several amino acids, organic acids, and key metabolic intermediates
(i.e., pyruvate) that limit carbon acquisition and energy generation. Growth studies determined that
the parent strain grew in LB containing 14 to 15% bile or bile salts, while the hns mutant grew in
6.5 and 9% of these compounds, respectively. Conversely, log-phase cells of the hns mutant were
significantly (p < 0.05) more acid tolerant than the parent strain and hns mutant complemented with
pSC0061. In mouse passage studies, the parent strain was recovered at a higher frequency (p <
0.01) than the hns mutant regardless of whether log- or stationary-phase phase cells were orally
administered.
Conclusion: These results demonstrate that H-NS is a powerful regulator of carbon and nitrogen
metabolism as well as tolerance to bile salts. It is likely that the metabolic impairments and/or the
reduced bile tolerance of the E. coli O157:H7 hns mutant decreased its ability to survive passage
through mice. Collectively, these results expand the influence of H-NS on carbon and nitrogen
metabolism and highlight its role in the ability of O157:H7 strains to respond to changing nutrients
and conditions encountered in the environment and its hosts.
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Background
Escherichia coli O157:H7 is a human pathogen that causes
hemorrhagic colitis in humans and in some cases may
incite hemolytic uremic syndrome [1]. Cattle are a princi-
pal reservoir and contaminated ground beef is most fre-
quently implicated in foodborne outbreaks associated
with this human pathogen [2,3]. Adult cattle harboring
serotype O157:H7 strains are asymptomatic, and the
numbers and duration of shedding are influenced by a
number of factors including feed, the microbial composi-
tion of the intestinal tract, the time of year, and environ-
mental sources [4]. The complex interplay between the
bovine host and E. coli O157:H7 persistence has not been
fully elucidated although Naylor et al. [5] recently demon-
strated localization and adherence to mucosal epithelium
in the recto-anal junction. The changing conditions
encountered by E. coli O157:H7 in the bovine intestinal
tract and the environment require that it closely control
metabolism and stress protection.
H-NS is a cytoplasmic protein that is abundant in the E.
coli nucleoid [6]. It plays a role in the condensation of
chromosomal DNA by binding to curved DNA and conse-
quently can influence the expression of many genes either
directly or indirectly [7,8]. The level of H-NS in cells
remains relatively constant throughout log- and station-
ary-phases although hns transcription is subject to auto
repression [9,10]. The production of over 60 proteins in E.
coli are either transcriptionally or translationally control-
led by H-NS [8,9,11]. Several genes modulated by H-NS
are responsive to changes in environmental conditions
like pH, osmolarity, and temperature [8,9,11-15]. The
involvement of H-NS in modulating genes responsive to
environmental stimuli make it an important regulator of
virulence in several pathogens including Shigella and Sal-
monella [12,13,16-19].
Although there has been considerable work on gene regu-
lation by H-NS, there has been comparatively little work
on its impact on bacterial metabolism and stress toler-
ance. Considering the varied and changing environments
encountered by E. coli O157:H7, a detailed understanding
of the consequences of modulators that are responsive to
environmental conditions is particularly important. To
this end, an hns  mutant was constructed to define the
growth and metabolic changes and any subsequent
impact on gastrointestinal passage in this important
human pathogen.
Results
Generation and confirmation of the hns::nptI mutant
A 695-bp fragment that includes the hns structural gene
and upstream regulatory region was amplified by PCR
from genomic DNA of E. coli O157:H7 ATCC 43895. The
nucleotide sequence of the EcoRI-BamHI fragment was
determined and was identical to the sequenced gene in E.
coli  O157:H7 EDL933 [20]. Transconjugants resulting
from the conjugation of pSC0063 from E. coli SM10 λpir
to E. coli O157:H7 strain ATCC 43895 were kanamycin
resistant, ampicillin sensitive, sucrose positive, and O157
positive. Confirmation of a double crossover in which
wild-type hns was replaced with hns::nptI was confirmed
by PCR (data not shown). PCR analysis of genomic DNA
from the parental strain (ATCC 43895) with primers
choi9917 and choi9918 generated a 375-bp fragment;
whereas, genomic DNA from the hns::nptI  mutant
(FRIK47001P) resulted in a DNA fragment approximately
1.6-kb in length. The 1.6-kb fragment is in agreement with
the projected size of the DNA fragment containing wild-
type hns (375 bp) and the nptI gene (1.2 kb).
Growth and serological characteristics
The growth of the hns  mutant (FRIK47001P) in LB at
37°C was slower and reached a lower maximum optical
density than the parent strain or FRIK47001P containing
pSC0061 (data not shown). The doubling times of the
parent, complemented, and mutant strains were 27, 34,
and 36 minutes, respectively. The maximum OD600 nm
achieved by the parent and complemented strains was 1.3
to 1.4 after 18 h of incubation while the hns  mutant
reached a maximum OD600 nm = 1.0. Similar to the results
in LB, the growth of the hns mutant in LB supplemented
with mucin or in fecal slurries was slower and reached a
lower final density than the parent strain. In addition, the
colony size of the hns mutant on agar media was smaller
than the parent and complemented strains. The presence
of kanamycin in the growth media did not influence the
growth of the mutant. These results are in agreement with
results with hns mutants of non-pathogenic E. coli which
had greater doubling times than the parent strains
[11,21]. One contributor to the longer doubling time is
the increased σs level in the hns mutant, which is partially
suppressed in hns rpoS double mutants [11]. The hns
mutant tested negative for the H7 antigen and was non-
motile in motility medium (data not shown); however,
the O157 antigen was still detected. The absence of H7 is
consistent with previous data showing that H-NS is
involved in the control of flagella gene expression and
that hns mutants are non-motile [22,23].
Growth inhibition by pH, NaCl, and bile
In addition to slower growth, the hns mutant was more
susceptible to inhibition by low pH, NaCl, bile (Table 1)
and cefixime (data not shown) compared to the parent
and complemented strains. Low temperature further
slows the growth of hns mutants [24]. Thus, the growth of
the mutant was further restricted when low temperature
was combined with another inhibitor. The minimum
growth pH of the hns mutant at the different temperatures
was 4.5 to 5.0 which was 0.5 to 1.0 pH unit higher thanBMC Microbiology 2006, 6:72 http://www.biomedcentral.com/1471-2180/6/72
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the parent and complemented strains with the greatest
difference observed at the lowest incubation temperature
(16.5°C). Both the parent and complemented strains
grew at pH 4.0 at each incubation temperature. Similar to
the results with pH, the hns mutant grew in LB supple-
mented with a maximum of 4–6% NaCl compared to 6–
7% for the parent and complemented strains. The test
strains tolerated the highest concentration of NaCl when
incubated at 25°C. There was one exception in which the
hns mutant complemented with pSC0061 grew in a max-
imum of 4% NaCl at 16.5°C which was equivalent to the
maximum level tolerated by the hns mutant. It is unclear
why the complemented strain differed from the parent
strain in this case where in all other growth conditions the
results were the same. An unexpected finding was the abil-
ity of the E. coli O157:H7 to grow in LB containing bile
compounds at 14–15%. The hns mutant was significantly
more sensitive to bile salts and bovine bile preparations
and grew in the presence of a maximum of 6.5% and 9.0%
of these compounds, respectively. The growth of the
strains in the presence of bile was further studied in LB
containing 5% bile salts. Although the hns mutant grew, it
had a greatly extended lag period (approximately 40 h) in
comparison to the parent and complemented strains (<12
h) (Figure 1).
Acid tolerance
The acid tolerance of the parent, hns mutant, and comple-
mented strains was tested using both log- and stationary-
phase cells. The survival of log-phase cells of the hns
mutant was significantly greater (p < 0.05) than the parent
strain when challenged in synthetic gastric fluid (pH 2.0)
(Figure 2A). These findings are consistent with the dere-
pression of σs (rpoS)-regulated genes in the absence of H-
NS. Stationary phase increased the acid tolerance com-
pared to log phase in all three strains and the numbers
decreased by less than 1 log10 CFU/ml after 3 h of acid
challenge (Figure 2B). However, the parent and hns-com-
Effect of bile salts on the growth of E. coli O157:H7 43895  (parent) and hns mutant (FRIK47001P) Figure 1
Effect of bile salts on the growth of E. coli O157:H7 
43895 (parent) and hns mutant (FRIK47001P). 
Growth of the parent strain (❍), hns mutant (), and hns 
mutant complemented containing pSC0061 (Δ) in LB contain-
ing 5% bile salts number three at 37°C. Data points are the 
average values from three trials.
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Table 1: Growth of Escherichia coli O157:H7 strains in LB as influenced by pH, temperature, NaCl, and bile compounds.
Growth in LB
Growth conditions ATCC 43895 (parent strain) FRIK47001P (hns mutant) FRIK47001P (pSC0061)
pHa
37°C 4.0 4.5 4.0
25°C 4.0 4.5 4.0
16.5°C 4.0 5.0 4.0
NaCl (%)b
37°C 6.0 5.0 6.0
25°C 7.0 6.0 7.0
16.5°C 6.0 4.0 4.0
Bile salts (%)c 14.0 6.5 14.0
Bile (%)d 15.0 9.0 15.0
aMinimum pH at which growth occurred. LB adjusted to appropriate pH with 5 N HCl.
bMaximum percent NaCl in LB at which growth occurred.
cBile salts No. 3 (Difco). Maximum percent in LB that growth occurred at 37°C.
dBovine bile (Sigma). Maximum percent in LB that growth occurred at 37°C.BMC Microbiology 2006, 6:72 http://www.biomedcentral.com/1471-2180/6/72
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plemented strains exhibited similar acid tolerance that
was significantly greater (p < 0.05) than the hns mutant.
In contrast to the findings with acid challenges conducted
in synthetic gastric fluid that is acidified with hydrochloric
acid, there was no difference in the survival of the parent
and hns mutant strains challenged in LB acidified with
acetic or lactic acids (data not shown).
Glutamate decarboxylase activity
In an attempt to discern the reduced acid tolerance in sta-
tionary-phase cells of the hns mutant, glutamate decarbox-
ylase (GAD) activity was measured (ΔpH/h/108 CFU). The
hns mutant had significantly less (p < 0.01) GAD activity
than the parent strain and strain FRIK47001P comple-
mented with pSC0061 (p < 0.001) when examining sta-
tionary-phase cells (data not shown). These findings
provide one possible explanation for the reduced acid tol-
erance in comparison to the parent strain of the hns
mutant in stationary phase.
Sole carbon and nitrogen sources
Metabolic characterization using Phenotype Microarrays
showed that the hns mutant was incapable of utilizing 42
carbon and 19 nitrogen sources that the parent strain
metabolized (Tables 2 and 3). The ability of the hns
mutant to uptake and/or use a variety of substrates as sole
carbon sources was significantly altered. The parent strain
was able to use six amino acids as sole carbon sources that
the hns mutant was unable to utilize. The mutant did not
use several disaccharides (rhamnose, lactulose, sucrose,
maltose) and trehalose, dulcitol, D-ribose, and dextrin. In
addition, eight organic acids, including pyruvate, were not
used as a sole carbon sources by the hns mutant (Table 3).
H-NS is involved in the regulation of genes associated
with carbohydrate metabolism, like the maltose operon
[25], but there were no carbon sources that were metabo-
lized by the mutant that were not utilized by the parent
strain. The parent strain metabolized six amino acids as
sole nitrogen sources that the hns mutant was unable to
use; however, the mutant was capable of using several
dipeptides (Table 3). Nitrite was one nitrogen source that
was utilized by the hns mutant but not the parent strain
(data not shown). The findings from this metabolic char-
acterization greatly expand the role of H-NS as a regulator
of carbon and nitrogen metabolism in E. coli.
Gastrointestinal passage
Testing of fecal samples prior to inoculation determined
that mice were E. coli O157:H7 negative and that few bac-
teria grew on the selective agar that were similar to the
inoculation strain (i.e., sorbitol negative). The administra-
tion of the parent strain, hns mutant (FRIK47001P), and
hns mutant complemented with pSC0061 did not result
in signs of illness in ICR mice. Although mice were tested
for 3 days post inoculation, all mice that shed the inocu-
lated E. coli O157:H7 strain tested positive one day after
inoculation and some mice continued to shed the strain
at day 2. No fecal samples tested positive at day 3. The
results from three trials are shown in Table 4. The parent
Acid tolerance of E. coli O157:H7 43895 (parent) and hns  mutant (FRIK47001P) Figure 2
Acid tolerance of E. coli O157:H7 43895 (parent) and 
hns mutant (FRIK47001P). Survival of the parent strain 
(●), hns mutant (■), and hns mutant complemented contain-
ing pSC0061 (▲) in simulated gastric fluid (pH 1.5) at 37°C 
when using log-phase (A) and stationary-phase (B) cells. Data 
points are the average values from at least three trials. Error 
bars represent the standard error of the mean.
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strain was recovered from a total of 13 mice of 27 inocu-
lated with log-phase cells (3 trials and 3 inoculation
doses) while only a single mouse receiving the hns mutant
tested positive at a dose of 103 CFU. The results between
the parent and hns mutant were statistically different (p <
0.01) at a dose of 104. Similar results were obtained with
stationary-phase cells of the parent strain, which was
detected in a total of 17 of 27 mice inoculated. The pas-
sage of the hns mutant was not improved when stationary-
phase cells were administered, and the feces from only 1
mouse (dose of 104 CFU) of 27 inoculated tested positive.
At doses of 103 and 104 CFU, the results with stationary-
phase cells of the parent strain were statistically different
(p < 0.05 and p < 0.01, respectively) from those obtained
with the hns mutant. The passage of the hns mutant com-
plemented with a functional hns in pSC0061 was similar
to that of the parent strain (data not shown). The dimin-
ished passage of the hns mutant was further demonstrated
when the percent of the dose surviving passage through
the mouse was calculated. Approximately, 7.9% of the
parent strain and 4.2% of the hns mutant complemented
with pSC0061 were recovered in feces compared to only
0.2% of the hns mutant that was determined from the few
fecal samples that harbored the mutant. These results
demonstrate that H-NS significantly impacts gastrointesti-
nal passage in mice.
Discussion
E. coli O157:H7 must respond to changing environmental
conditions whether it is present in the gastrointestinal
tract or the environment [26]. Metabolic pathways must
be carefully controlled and stress-protection systems trig-
gered in a timely manner to effectively compete and sur-
vive. H-NS is a major component of the bacterial
nucleoid, having pleiotropic effects on gene expression,
genome stability and DNA recombination [9,27]. H-NS is
Table 2: Sole carbon source metabolism by the E. coli O157:H7 parent (ATCC 43895) and hns mutant (FRIK 47001) strains.
Carbohydrates and derivatives Amino acids and derivatives Organic acids Other
Utilized by the parent strain but not the hns mutant
Dextrin D-Alanine Acetic acid
Dulcitol L-Alanine Formic acid
3-O-β-D-Galactopyranosyl-D-arabinose L-Alaninamide L-Glutamic acid
L-Galactonic acid-lactone L-Asparagine D-Glucuronic acid
α-methyl-D-Galactoside glycyl-L-Aspartic acid L-Lactic acid
β-methyl-D-Galactoside glycyl-L-Glutamic acid D-Malic acid
β-methyl-Glucoside L-Glutamine L-Malic acid
D-L-αGlycerol phosphate L-alanyl-Glycine D, L-Malic acid
Lactulose glycyl-L-Proline Melibionic acid
Maltose L-Serine Mucic acid
N-acetyl-β-D-Mannosamine Propionic acid
L-Rhamnose Putrescine
D-Ribose Pyruvic acid
Sucrose methyl Pyruvate
Succinic acid bromo Succinic acid
D-Trehalose mono methyl Succinate
Utilized by the parent and hns mutant strains
L-Arabinose D-Galacturonic acid Adenosine
L-Fucose D-Gluconic acid 2-deoxy Adenosine
D-Fructose N-acetyl-Neuraminic acid N-acetyl-D-Galactosamine
Fructose-6-phosphate N-acetyl-D-Glucosamine
D-Galactose Inosine
α-methyl-D-Galactoside Thymidine
Glucose-1-phosphate Uridine
Glucose-6-phosphate
α-D-Glucose
Glycerol
α-D-Lactose
Maltotriose
D-Mannitol
D-Mannose
D-Melibiose
D-Psicose
D-Raffinose
D-XyloseBMC Microbiology 2006, 6:72 http://www.biomedcentral.com/1471-2180/6/72
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involved in the control of several genes in E. coli associ-
ated with the metabolism of specific substrates as well as
stress protection [8,9,15]; such as Lrp (leucine-responsive
regulatory protein), σs (rpoS), and two-component sys-
tems (PhoP, EvgA and YedW) [8]. Thus, H-NS is a master
regulator affecting the expression of individual genes and
regulons with several of the phenotypes observed in hns
mutants occurring as a result of indirect effects on gene
expression [8,27].
In our studies of an hns mutant of E. coli O157:H7, the
growth was slower than the parent strain. Although it is
not completely understood, the increased doubling time
in hns mutants is partially related to the increased level of
σs and the possibility of secondary site mutations that
affect growth [11]. H-NS negatively influences the level of
σs at the posttranscriptional level [9,28,29], and the level
of σs increases in log-phase cells of hns mutants [11,30].
Another factor that contributes to the level of σs in hns
mutants is the increase in the heat-shock chaperone DnaK
which enhances σs stability [15]. The increase in σs results
in the production of σs-regulated proteins some of which
are involved in stress protection [8,15,30]. Results from
this study using phenotypic microarrays showed that H-
NS has a significant impact on carbon and nitrogen
metabolism that likely impact the growth of the mutant
(Tables 3 and 4). Among the substrates that were not
metabolized were several carbon and nitrogen sources,
including several key metabolic intermediates (Figure 3)
that likely influence growth and energy generation. It is
probable that the slower growth of the hns mutant is a
result of the combined effects of the increased level of σs
[11] and altered substrate metabolism. However, another
possibility that cannot be excluded is the generation of a
second site mutation that influenced growth [11,40].
Table 3: Sole nitrogen source metabolism by the E. coli O157:H7 
parent (ATCC 43895) and hns mutant (FRIK 47001) strains.
Amino acids and derivatives Peptides Other
Utilized by the parent strain but not the hns mutant
D-Alanine Ala-His Alloxan
L-Alanine Ala-Leu γ-amino-N-Butyric acid
L-Arginine Ala-Thr Cytosine
L-Cysteine N-acetyl-D-Galactosamine
Glycine D-Glucosamine
L-Proline N-acetyl-D-Glucosamine
L-Tryptophan Glucuronamide
N-acetyl-D-Mannosamine
L-Ornithine
Xanthine
Xanthosine
Utilized by the parent and hns mutant strains
L-Aspartic Acid Ala-Asp Adenine
L-Asparagine Ala-Gln Adenosine
L-Glutamic Acid Ala-Glu Ammonia
L-Glutamine Ala-Gly Cytidine
L-Serine Gly-Asn
Gly-Gln
Gly-Glu
Gly-Met
Met-Ala
Table 4: Recovery of E. coli O157:H7 strains ATCC43895 (parent) and FRIK47001P (hns mutant) from feces following oral 
administration to ICR mice.a
E. coli dose (CFU) No. of mice with a positive fecal sample for E. coli O157:H7 in each trial with three mice inoculated per trial (total no. of 
positive mice/9 mice examined in 3 trials)
Trial with log-phase cells Trial with stationary-phase cells
I II III I II III
Strain 43895 
(parent)
102 001  ( 1 ) 013  ( 4 )
103 203  ( 5 ) 023  ( 5 )
104 313  ( 7 ) 332  ( 8 )
Strain 47001P (hns 
mutant)
102 000  ( 0 ) 000  ( 0 )
103 100  ( 1 ) 000  ( 0 ) b
104 000  ( 0 ) c 100  ( 1 ) c
aCell pellets of the parent and hns mutant strains were resuspended and diluted to the appropriate cell number in 10% sucrose. Each mouse was 
administered 0.5 ml of the sucrose solution containing the designated dose of cells. Results are from fecal pellets collected 12–14 h after oral 
administration.
bSignificantly different (p < 0.05) from results with the parent strain at a dose of 103 CFU.
cSignificantly different (p < 0.01) from results with the parent strains at a dose of 104 CFU.BMC Microbiology 2006, 6:72 http://www.biomedcentral.com/1471-2180/6/72
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The growth of the hns mutant was also more susceptible
to inhibition by NaCl and bile salts than the parent strain
(Table 1). These differences were accentuated by sub-opti-
mal growth temperature, often encountered when outside
of the intestinal tract. A significant finding from these
growth comparisons was the high tolerance of the parent
E. coli O157:H7 strain to bile and bile salts (15 and 14%,
respectively), while the growth of the hns mutant was lim-
ited to a maximum of 9.0 and 6.5%, respectively. Bile salts
are produced by the liver to breakdown fat and are delete-
rious to biological membranes. E. coli must tolerate bile
salts that can reach concentrations of 20 mM in the duo-
denum and even higher in the small intestine [31]. The
reduced capacity of the mutant to tolerate bile salts might
be a consequence of membrane changes in the hns
mutant. H-NS is known to influence expression of at least
5% of the genes in E. coli, many that encode for mem-
brane proteins [8]. The possibility of an altered mem-
brane is supported by the inhibition of the mutant by the
cephalosporin-like antibiotic, cefixime, while the parent
strain grew in media containing 0.4 μg cefixime/ml.
Future studies with H-NS-deficient strains should be use-
ful in identifying the proteins involved in bile tolerance in
E. coli O157:H7 strains.
Acid tolerance is one characteristic that influences the per-
sistence of E. coli O157:H7 shedding in cattle [32] and
may promote survival during gastric passage in humans
[33]. The increased acid tolerance of the hns mutant in
comparison to the parent strain in log-phase cells is con-
sistent with the expression of σs-regulated proteins [9]. In
stationary-phase cells, the acid tolerance increased in all
three strains (parent, hns mutant, and hns complemented
strains) in comparison to log-phase cells. However, the
hns mutant was less acid tolerant than the parent strain in
stationary phase. The gad system comprised of GadA and
Key carbon sources that were not metabolized by the E. coli O157:H7 hns mutant Figure 3
Key carbon sources that were not metabolized by the E. coli O157:H7 hns mutant. Some of the metabolic interme-
diates and substrates that were not (, open box) metabolized as sole carbon sources by the hns mutant of E. coli O157:H7 
when examined using Phenotypic Microarrays. Both the parent and hns mutant strains metabolized the compounds that are 
not in boxes. Compounds in italics which were not tested (a). E. coli converts glutamate and oxaloacetate to α-ketoglutarate 
and aspartate (b) [55,56]. Glycyl-L-proline was tested (c). α-ketoglutarate was not metabolized as a sole carbon source by nei-
ther the parent strain nor the hns mutant (d).
TCA cycle
Glucose
3-phosphoglyceraldehyde
Pyruvate
Serine
Alanine
Malic acid
Succinic acid
Propionic acid
Acetic acid
Lactic acid
afumarate Aspartate
Asparagine
b,dD-ketoglutarate Glutamate
Glutamine
cProline
a,boxaloacetateBMC Microbiology 2006, 6:72 http://www.biomedcentral.com/1471-2180/6/72
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GadB, two isoforms of glutamate decarboxylase, and gadC
that encodes for a glutamate/γ-aminobutyrate antiporter
[34-38] is one contributor to acid tolerance. Results from
the phenotype microarrays showed that the hns mutant
did not utilize glutamate as a sole carbon source; there-
fore, we compared glutamate decarboxylase activity in sta-
tionary-phase cells of the mutant and parent strains. The
specific activity of glutamate decarboxylase was reduced
in the hns  mutant (p < 0.01) compared to the parent
strain. The decreased specific acitivity of glutamate decar-
boxylase may explain the difference in acid tolerance
between the hns mutant and parent strain in stationary-
phase cells.
In mouse passage studies, recovery of the hns mutant was
significantly less than the parent strain (Table 2). The
mutant was recovered from a single mouse in each of
three trials conducted with log-phase and stationary-
phase cells. It is possible that the reduced ability of the hns
mutant to survive mouse passage is a consequence of a
depleted energy supply, resulting from its limited capacity
to metabolize available substrates, which is necessary for
the optimal functioning of homeostasis or stress protec-
tion systems (i.e., ATPase). Gene expression profiles of
mucus-grown E. coli have identified genes involved in the
catabolism of gluconate, N-acetylglucosamine, sialic acid,
glucuronate, mannose, fucose, and ribose are induced and
considered preferred carbon sources [39]. Mutants incapa-
ble of metabolizing these seven carbohydrates have a
decreased capacity to colonize streptomycin-treated mice.
Although the mouse passage assay employed in this study
did not evaluate colonization, the results from Phenotype
Microarrays found that five of the seven carbohydrates
identified by Chang et al. [39] as preferred carbon sources
were utilized by the hns mutant while the E. coli O157:H7
parent strain used all seven carbon sources (see Tables 2
and 3). In addition, the hns mutant grew in mucin-supple-
mented LB broth and fecal slurries to a concentration
essentially equivalent to that of the parent strain although
the lag-phase was longer and the growth rate slower than
that of the parent strain which is similar to the results
obtained in growth studies conducted in LB. Therefore, a
defect in the ability to utilize a mucin carbohydrate is
probably not the reason for the reduced passage of the hns
mutant.
There are a number of possible antimicrobial factors in
the gastrointestinal tract that may be responsible for the
diminished capacity of the hns mutant to survive passage
through ICR mice. Acetate can reach a concentration of 70
mM in the intestinal tract [41,42]. Although log-phase
cells of the mutant were more acid tolerant in challenges
conducted with hydrochloric acid, additional challenges
were conducted with acetic and lactic acids because results
from phenotype microarrays found that the mutant did
not utilize acetate or lactate as sole carbon sources. It was
reasoned that tolerance to these acids might be impaired,
but acid challenges with lactic acid and acetic acid at pH
4.4 found no difference in the survival of the parent and
hns mutant strains with log- or stationary-phase cells (data
not shown). Another possibility is that bile salts may have
affected passage of the hns mutant through mice. In addi-
tion to being inhibitory, bile in association with H-NS is
known to repress virulence genes [43]. However, addi-
tional experiments are needed with bile-sensitive mutants
and measurements of bile acid concentrations in the
mouse intestinal tract to confirm that bile was responsible
for the reduced recoveries of the hns mutant. Considering
that the intestinal tract contains at least 500 bacterial spe-
cies [39], it is also possible that one of the commensal
microbes produces an antimicrobial factor that is detri-
mental to the hns mutant. Studies with gnotoxenic mice
would be particularly valuable in addressing the contribu-
tions of competing flora on the survival of the hns mutant.
Based upon the results from this study, the most plausible
explanation for the reduced passage of the hns mutant
through mice is the regulatory impairments that influence
growth and stress protection.
Conclusion
Results from this study significantly expand the impor-
tance of H-NS in carbon and nitrogen metabolism (Figure
3) as well as stress tolerance that collectively influence the
ability of E. coli O157:H7 to respond to changing condi-
tions it encounters in its host and the environment. This
is the first report of the high tolerance of E. coli O157:H7
strains to bile and bile salts that may be of significance in
localization and persistence within its bovine host and
possibly during human infection. Studies are in progress
to identify, which proteins that are influenced by H-NS
contribute to bile tolerance. The results from this study
also establish H-NS as a potential target for control of this
important human pathogen.
Methods
Bacterial strains and culture conditions
The bacterial strains and plasmids used in this study are
listed in Table 5. E. coli were grown in Luria-Bertani (LB)
broth at 37°C. Antibiotics (Sigma Chemical Company, St.
Louis, MO) were added to media when appropriate: amp-
icillin, 100 μg/ml; kanamycin, 50 μg/ml; and tetracycline,
10 μg/ml. For log-phase and stationary-phase cultures, 5
μl of an overnight culture was used to inoculate 5 ml of LB
and incubated with shaking (150 rpm) at 37°C to an opti-
cal density at 600 nm = 0.5 (log phase, ~108 CFU/ml) and
optical density at 600 nm = 1.1 (stationary phase, ~109
CFU/ml), respectively.BMC Microbiology 2006, 6:72 http://www.biomedcentral.com/1471-2180/6/72
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Generation and confirmation of an hns::nptI mutant
A DNA fragment containing the hns structural gene and
flanking regions was amplified from genomic DNA of E.
coli O157:H7 ATCC 43895 by PCR using oligonucleotide
primers (choi0005, 5'-TTTGGATCCAAAGCCTGGCTT-
GAAGAAGAGATG-3' and choi0006, 5'-TTTGAATTCTTTT-
GAATTCCTTACATTCCTGGC-3') containing an EcoRI
(choi0005) and BamHI (choi0006) site on the respective
5'-ends. After PCR amplification, the PCR fragment was
digested with EcoRI and BamH1 and ligated into pBR322,
previously digested with the same enzymes, to produce
pSC0061. The nucleotide sequence of the cloned frag-
ment was determined (University of Wisconsin-Biotech-
nology Center). The suicide vector, pCVD442, was used to
generate hns mutant in E. coli O157:H7 ATCC 43895 by
homologous recombination. The hns  gene in pSC0061
was inactivated by insertion of nptI  encoding for
aminoglycoside 3'-phosphotransferase (confers resistance
to kanamycin) digested from pUC4K [44] using PstI and
gap filled with Klenow fragment. nptI was ligated with a
partial PstI digest of pSC0061 carrying hns which has a PstI
site present within its open reading frame (ORF). The con-
struct (pSC0062) was digested with EcoR1 and BamH1 to
liberate the 1.9-kb hns::nptI fragment. The fragment was
blunt-ended with Klenow and ligated with SmaI-digested
pCVD442 [45] to produce pSC0063. The constructed vec-
tor was conjugally mobilized from E. coli SM10 λ pir [46]
carrying the tra gene to recipient strain E. coli O157:H7
43895. Conjugation and mutant selection were con-
ducted as described previously [47]. Transconjugants that
were kanamycin resistant, ampicillin sensitive and tested
positive for the O157 antigen by latex agglutination
(Oxoid, Basingstoke, England) were selected for further
study. The primers choi9917 (5'-ATGAGCGAAGCACT-
TAAAATTCTGAAC-3') and choi9918 (5'-TTCTTCCATT-
GCTTTTTTGATTACAGC-3') were used to amplify a
portion of the hns ORF and confirm the presence of nptI
in hns (1.6-kb fragment) (data not shown). FRIK 47001
(hns::nptI) was complemented by transforming FRIK
47001 with pSC0061.
Phenotype MicroArrays
The analysis of sole carbon and nitrogen source utiliza-
tion was conducted with Phenotype MicroArrays™
(Biolog, Hayward, Calif.). This method is used to identify
the function and global interactions of a gene on cellular
metabolism [48,49]. The parent E. coli O157:H7 strain
ATCC 43895 and hns::nptI mutant (FRIK47001) were
evaluated for their ability to use carbon and nitrogen
sources using PM1, PM2, and a PM3 plates, respectively.
Strains were grown on R2A agar (Biolog) overnight at
37°C and sufficient cells were transferred to inoculating
fluid to equal the 85%T turbidity standard (Biolog).
FRIK47001 was resuspended in inoculating fluid contain-
ing glucose rather than succinic acid when inoculating the
PM3 plate because it was unable to use succinic acid as a
carbon source. Each well was inoculated with 100 μl of
the standardized cell suspension, incubated at 37°C for
48 h, and the results recorded.
Growth studies
Growth studies were conducted in LB adjusted to the
appropriate pH or supplemented with NaCl, bile, bile
salts, or cefixime using the parent, hns mutant, and hns
mutant complemented with pSC0061. Cells were used to
inoculate the adjusted LB medium at a final concentration
Table 5: Plasmids and E. coli strains used in this study.
Strain or plasmid Relevant characteristicsa Source or reference
Strains
DH5α supE44 ΔlacU169 (ϕ80 lacZ ΔM15)hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Lab collection
ATCC 43895 stx1 and stx2; other designation EDL 933W Lab collection
SY327 λpir Δ(lac pro) argE(Am) recA56 nalA Rif(λpir); π protein for R6K γ ori [57]
SM10 λpir thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu, λpir, oriT of RP4; Kmr [57]
FRIK47001Pb ATCC 43895, hns::nptI This study
Plasmids
pBR322 Apr and Tcr Lab collection
pUC4K pUC4 with nptI; Apr, Kmr Pharmacia, [44]
pCVD442 R6K γ ori, sacB, oriT of RP4; Apr J. Kaper, [45]
pSC9916 pBR322 containing Apr, Tcs [47]
pSC0061 pSC9916 containing hns; Tcs, Apr This study
pSC0062 pSC0061, hns::nptI This study
pSC0063 pCVD442 containing hns::nptI This study
a Apr, ampicillin resistant; Aps, ampicillin sensitive; Kmr, kanamycin resistant; Tcr, tetracycline resistant; Tcs, tetracycline sensitive. Antibiotics were 
added to media when appropriate at the following concentrations: ampicillin 100 μg/ml, kanamycin 50 μg/ml, tetracycline 10 μg/ml.
b FRIK47001P hns::nptI in the parallel orientation.BMC Microbiology 2006, 6:72 http://www.biomedcentral.com/1471-2180/6/72
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of 105 CFU/ml and incubated at 16.5, 25, and/or 37°C
without shaking. The minimum pH for growth was deter-
mined in the pH range of 3.5 to 7.0 at 0.5 increments. The
following were added to LB at the following ranges: NaCl,
0 to 10% (0.5% increments); bile salts no.3 (Difco), 0 to
16%; bovine bile (Sigma), 0 to 16%; porcine stomach
mucin (Sigma), 2.5 mg/ml; bovine submaxillary gland
mucin (Sigma), 2.5 mg/ml; and cefixime (Lederle), 0.2 to
0.8 μg/ml. Inoculated tubes were incubated at the desig-
nated temperature and observed daily for turbidity for up
to 21 days. The growth of the strains in the presence of bile
salts and mucin were studied in more detail. Growth in LB
supplemented with 5% bile salts or 2.5 mg mucin/ml was
monitored spectrophotometrically at 600 nm using a Bio-
screen Analyzer at 37°C for 48 h (Labsystems, Helsinki,
Finland). Plates were shaken for 30s prior to each optical
density reading. The growth of strains was also monitored
in fecal slurries (mouse feces diluted 1:10 in sterile deion-
ized water). The fecal slurries were inoculated at a final
concentration of approximately 105 CFU/ml from over-
night cultures grown in LB, and then incubated at 37°C.
Samples were removed and the number of CFU/ml deter-
mined by plating on MacConkey sorbitol agar (MSA,
Difco) supplemented with 2.5 μg potassium tellurite/ml
(Fisher) and 0.05 μg cefixime/ml (Lederle Laboratories,
Pearl River, NY) [50] and enumerating the number of
sorbitol-negative colonies.
Acid challenge
Acid tolerance was assessed in synthetic gastric fluid
adjusted to pH 1.5 and LB acidified with acetate or lactate
(pH 4.4) as previously described [51]. Log (OD600 = 0.5)
and stationary (OD600 = 1.1) phase cells were used to
inoculate flasks containing 50 ml of synthetic gastric fluid
or acidified LB to achieve a final concentration of ca. 105
CFU/ml. Flasks were incubated at 37°C with shaking (150
rpm). Samples were removed periodically and then plated
on tryptic soy agar (TSA, Difco) using a Model D Spiral
Plater (Spiral Systems Inc., Cincinnati, OH). The number
of colony forming units (CFU) was determined after 24 h
of incubation at 37°C. The survival curves shown are the
mean values from at least three trials.
GAD activity
The cells were examined for GAD activity as previously
described [52,53] with the following modifications.
Strains were cultured overnight in LB at 37°C for 21 h.
The cells from 1.0 ml were pelleted by centrifugation and
washed with 0.9% NaCl. The cells were resuspended in
3.0 ml of GAD reagent (1 g of L-glutamic acid, 0.05 g of
bromocresol green, 90 g of NaCl, and 3 ml of Triton X-100
per liter) and incubated for 3 h at 35°C. The color and pH
change of the reaction mixture was recorded every 30 min-
utes. GAD activity was reported as the ΔpH/h/108 cells.
The mean values were calculated from at least three trials.
Mouse inoculation studies
The passage studies were conducted as previously
described [32]. In brief, strains were grown in LB at 37°C
to log and stationary phase. After harvesting and washing
with PBS, the cells were resuspended in 10% sucrose or
phosphate buffer (0.01 M, pH 7.4) to a concentration of
104, 103, or 102 CFU/ml and administrated to individually
housed ICR mice (ca. 20 g, Harlan Sprague Dawley Inc.,
Madison, Wis). Three trials were conducted, and in each
trial three mice were inoculated with each concentration
of the test strain. Fecal samples were collected each day for
3 days after inoculation and tested for the presence or
absence of E. coli O157:H7. Fecal samples were diluted
(1:10) in modified EC broth supplemented with novo-
biocin (20 μg/ml) and incubated at 37°C with shaking
(150 rpm) for 18–24 h. Following enrichment, 20 μl of
Dynabeads® anti-E. coli O157 (Dynal Biotech ASA, Oslo,
Norway) was added to 0.5 ml of the enriched fecal culture
and wash buffer (0.5 ml), incubated, and washed as
described by the manufacturer. The resuspended beads
were streaked on MacConkey sorbitol agar supplemented
with potassium tellurite/ml and cefixime/ml [50]. The
plates were incubated at 42°C for 24 h and examined for
sorbitol-negative E. coli O157:H7 colonies. Suspect colo-
nies were confirmed as O157 by agglutination (E. coli
O157:H7 test kit, Oxoid). The minimum detection level
of this procedure was approximately 100 CFU/g.
Statistical analyses
The data presented are the mean values from at least three
trials. The acid tolerance of strains was compared using
the inverse of slopes from linear regression plots of survi-
vor curves. The data from acid challenges were analyzed
for statistical differences by one-way analysis of variance.
A z-test for was used to evaluate significant differences in
the proportions of mice testing positive between inocula-
tion strains [54]. All calculations were conducted using
SigmaStat software (Jandel Scientific, San Rafael, Calif.).
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